Aug 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2016 Jun 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 16.49 14.73 66.00
(+12.0 pct) (+0.1 pct) (+5.6 pct)
Operating 1.72 1.03 4.80
(+67.4 pct) (+19.7 pct) (+5.1 pct)
Recurring 1.83 594 mln 4.60
(+208.1 pct) (-36.9 pct) (+3.4 pct)
Net 1.33 891 mln 3.60
(+49.0 pct) (-15.0 pct) (+2.5 pct)
EPS 25.01 yen 16.79 yen 67.78 yen
Ann Div 31.00 yen 32.00 yen
-Q2 div 15.00 yen 16.00 yen
-Q4 div 16.00 yen 16.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))